Chinese Journal of New Drugs 2010 Issue 17 Procarbazine induces A:T→T:A transversion in the cII gene in Muta~(TM) Mouse

Procarbazine induces A:T→T:A transversion in the cII gene in Muta~(TM) Mouse
WANG Xue1;MA Rui1;DENG Yuan-yuan1;SUZUKI Takayoshi2

..............page:1616-1620

xian dai yao wu yu lin chuang za zhi 2011 nian zheng ding qi shi

..............page:1626

Pharmaceutical care in adverse reactions of gefitinib and gemcitabine in treating lung cancer
LI Jing1;PAN Hong-ming2;SHEN Li-rong2

..............page:1624-1626

fda you xian shen pi sprycel zhi liao xin zhen duan de man xing sui xing bai xue bing de bu chong xin yao shang shi shen qing

..............page:1520

curis gong si shou dao lai zi debiopharm gong si dui debio-0932 de fen qi fu kuan

..............page:1570

Relationship between the initiation,development and therapy of tumor and inflammation
JI Deng-bo;CUI Jing-rong

..............page:1551-1555

Synthesis and anti-tumor activity of luteinizing hormone-releasing hormone-methotrexate
WU Xue-ping1;XIE Ming-jun2;SUN Yan1;PAN Li-jun1;WANG Chi1

..............page:1609-1612

Compound matrine injection combined with DCF chemotherapy in the treatment of 25 patients with advanced gastric carcinoma
WANG Juan;WANG Ke-ming;WANG Zhao-xia;LU Bin-bin;LI Juan

..............page:1585-1588

juan shou yu
sun yan ;';'';'au';'cjfq');

..............page:1483

2009 nian yao pin zhu ce shen pi nian du bao gao

..............page:1489-1493

Progress in analysis of findings in the standard battery of genotoxicity tests
ZHOU Chang-hui1;CHANG Yan1;LIN Hai-xia1;WANG Qing-li2

..............page:1512-1516

Advances in studies of anti-tumor activity of evodiamine
ZHANG Chun;LIANG Hua-ping

..............page:1558-1562

Effect of Kangai injection on quality of life in patients with advanced hepatic cancers
YANG Ru-yi;ZHANG Hong-wu

..............page:1575-1577,1584

Clinical significance of hMLH1 and hMSH2 expression in predicting outcomes of patients with non-small-cell lung cancer after platinum-based chemotherapy
NING Xiao-hong1;WANG Yu-zhou1;SUN Zhao1;LI Ji2;BAI Chun-mei1

..............page:1566-1570

Effect of gene mutations of epidermal growth factor receptor on the maintenance therapy of advanced non-small cell lung carcinoma
DU Yan-ping;JIANG Xing-tang;YIN Xiao-wen;YUAN Ya-ting

..............page:1580-1584

Procarbazine induces A:T→T:A transversion in the cII gene in Muta~(TM) Mouse
WANG Xue1;MA Rui1;DENG Yuan-yuan1;SUZUKI Takayoshi2

..............page:1616-1620

Advances in targeted treatment for gastric cancer
DENG Wei;SHEN Lin

..............page:1531-1538

xian dai yao wu yu lin chuang za zhi 2011 nian zheng ding qi shi

..............page:1626

Pharmaceutical care in adverse reactions of gefitinib and gemcitabine in treating lung cancer
LI Jing1;PAN Hong-ming2;SHEN Li-rong2

..............page:1624-1626

Progress and issues requiring attention in clinical application of targeted drugs for non-Hodgkin's lymphomas
SHI Yuan-kai;XING Pu-yuan

..............page:1521-1526

di shi si jie shi jie lin chuang teng tong da hui zuo di yi jie ya zhou teng tong da hui di si jie zhong guo lin chuang teng tong xue shu hui yi

..............page:1608

Effect of BCG vaccine on endometriotic implants in a rat model of endometriosis
WANG Xiao-qian1;WANG Hong-jing1;WANG Xue2;JIA Xi-biao3;ZHANG Na4;CHEN Hong-ju5

..............page:1600-1604

Preparation of docetaxel nanosuspension and its intravenous injection
LI Lin-sui;WANG Dong-kai

..............page:1613-1615,1620

Advances in clinical studies of targeted treatment for hepatocellular carcinoma
LI Qing;SUN Yan

..............page:1547-1550

fda you xian shen pi sprycel zhi liao xin zhen duan de man xing sui xing bai xue bing de bu chong xin yao shang shi shen qing

..............page:1520

curis gong si shou dao lai zi debiopharm gong si dui debio-0932 de fen qi fu kuan

..............page:1570

Current status and advances in targeted therapy for renal cell carcinoma
SHOU Jian-zhong;MA Jian-hui

..............page:1539-1546

Relationship between the initiation,development and therapy of tumor and inflammation
JI Deng-bo;CUI Jing-rong

..............page:1551-1555

Synthesis and anti-tumor activity of luteinizing hormone-releasing hormone-methotrexate
WU Xue-ping1;XIE Ming-jun2;SUN Yan1;PAN Li-jun1;WANG Chi1

..............page:1609-1612

Nilotinib,new standard of care for CML patients in the future
ZHOU Li;SHEN Zhi-xiang

..............page:1496-1499

Compound matrine injection combined with DCF chemotherapy in the treatment of 25 patients with advanced gastric carcinoma
WANG Juan;WANG Ke-ming;WANG Zhao-xia;LU Bin-bin;LI Juan

..............page:1585-1588

juan shou yu
sun yan ;';'';'au';'cjfq');

..............page:1483

Efficacy of irinotecan in combination with oxaliplatin in the treatment of metastatic colorectal cancer
LU Xi-yan;LIU Jin-ping;ZHOU Chang-fang

..............page:1578-1579,1588

2009 nian yao pin zhu ce shen pi nian du bao gao

..............page:1489-1493

Progress and issues requiring attention in clinical application of targeted drugs for non-Hodgkin's lymphomas
SHI Yuan-kai;XING Pu-yuan

..............page:1521-1526

Individualization:a new target of medical oncology in integration of modern medicine and traditional Chinese medicine
SUN Yan

..............page:1484-1488

Nilotinib,new standard of care for CML patients in the future
ZHOU Li;SHEN Zhi-xiang

..............page:1496-1499

Pharmaceutical patent and the protection of the public health
ZHAO Yu-gang

..............page:1500-1502,1507

shi jie xin yao zhi chuang

..............page:1494-1495

Guideline on the need for carcinogenicity studies of pharmaceuticals in China
WANG Qing-li;WANG Hai-xue;HU Xiao-min;SUN Tao;ZHANG Ruo-ming;WANG Yu-zhu;YAN Li-ping;GUANG Hong-mei;PENG Jian;FENG Yi

..............page:1508-1511

Transdermal absorption characteristics of brucine in vitro is affected by other alkaloids in total alkaloids from seed of Strychnos nux-vomica
LI Lei1;2;3;CHEN Jun1;CAI Bao-chang1;2;3

..............page:1517-1520

Comparison of drug standards and product quality of pemetrexed disodium for injection
LI Chen-gui1;YE Chao1;WANG Xiao-mei1;ZHOU Yuan-hua1;HU Yu-zhu1;2

..............page:1621-1623

Pharmaceutical patent and the protection of the public health
ZHAO Yu-gang

..............page:1500-1502,1507

Efficacy of pemetrexed therapy in patients with advanced non-small-cell lung cancer (adenocarcinoma) failed to previous chemotherapy and TKI
ZHU Guang-qing;JIN Ying;ZHANG Miao;ZHANG Yu-zhen

..............page:1596-1599

huan ying ding yue 2011 nian zhong guo yao wu hua xue za zhi

..............page:1612

Advances in targeted treatments for advanced non-small-cell lung cancer
WANG Yan;SUN Yan

..............page:1527-1530,1546

Management system of phase Ⅳ clinical trials
LIU Lu;WEN Bao-shu;HUANG Qing-zhu;FENG Yi;ZHANG Pei-pei;LI Guo-qing

..............page:1503-1507

Synthesis,characterization,crystal structure and physicochemical properties of picoplatin
PU Shao-ping1;2;CONG Yan-wei2;WANG Qing-kun2;BEI Yu-xiang2;LUAN Chun-fang2;LI Xue-jie2;SUN Jia-lin1

..............page:1605-1608

Gastrointestinal stromal tumor and its adjuvant therapy
ZHANG Yong;LU Wei;LU Wei-qi

..............page:1563-1565,1574

Application of gelatin sponge particles to the interventional treatment of hepatic carcinoma
ZHAO Guang-sheng;YANG Xiao-hong;LI Chuang;ZHANG Yue-wei;WANG Wen-qing;TANG Shun-xiong;WANG Ruo-yu

..............page:1571-1574

8-year follow-up update of International Randomized Study of Interferon vs STI571(IRIS)
XIAO Zhi-jian

..............page:1556-1557,1562

Guideline on the need for carcinogenicity studies of pharmaceuticals in China
WANG Qing-li;WANG Hai-xue;HU Xiao-min;SUN Tao;ZHANG Ruo-ming;WANG Yu-zhu;YAN Li-ping;GUANG Hong-mei;PENG Jian;FENG Yi

..............page:1508-1511

Transdermal absorption characteristics of brucine in vitro is affected by other alkaloids in total alkaloids from seed of Strychnos nux-vomica
LI Lei1;2;3;CHEN Jun1;CAI Bao-chang1;2;3

..............page:1517-1520

Progress in analysis of findings in the standard battery of genotoxicity tests
ZHOU Chang-hui1;CHANG Yan1;LIN Hai-xia1;WANG Qing-li2

..............page:1512-1516

Advances in studies of anti-tumor activity of evodiamine
ZHANG Chun;LIANG Hua-ping

..............page:1558-1562

Effect of Kangai injection on quality of life in patients with advanced hepatic cancers
YANG Ru-yi;ZHANG Hong-wu

..............page:1575-1577,1584

Clinical significance of hMLH1 and hMSH2 expression in predicting outcomes of patients with non-small-cell lung cancer after platinum-based chemotherapy
NING Xiao-hong1;WANG Yu-zhou1;SUN Zhao1;LI Ji2;BAI Chun-mei1

..............page:1566-1570

Effect of gene mutations of epidermal growth factor receptor on the maintenance therapy of advanced non-small cell lung carcinoma
DU Yan-ping;JIANG Xing-tang;YIN Xiao-wen;YUAN Ya-ting

..............page:1580-1584

Advances in targeted treatments for advanced non-small-cell lung cancer
WANG Yan;SUN Yan

..............page:1527-1530,1546

Comparison of drug standards and product quality of pemetrexed disodium for injection
LI Chen-gui1;YE Chao1;WANG Xiao-mei1;ZHOU Yuan-hua1;HU Yu-zhu1;2

..............page:1621-1623

Advances in targeted treatment for gastric cancer
DENG Wei;SHEN Lin

..............page:1531-1538

8-year follow-up update of International Randomized Study of Interferon vs STI571(IRIS)
XIAO Zhi-jian

..............page:1556-1557,1562

zhong guo yao xue za zhi 2011 nian zheng ding qi shi

..............page:1499

di shi si jie shi jie lin chuang teng tong da hui zuo di yi jie ya zhou teng tong da hui di si jie zhong guo lin chuang teng tong xue shu hui yi

..............page:1608

Effect of BCG vaccine on endometriotic implants in a rat model of endometriosis
WANG Xiao-qian1;WANG Hong-jing1;WANG Xue2;JIA Xi-biao3;ZHANG Na4;CHEN Hong-ju5

..............page:1600-1604

Preparation of docetaxel nanosuspension and its intravenous injection
LI Lin-sui;WANG Dong-kai

..............page:1613-1615,1620

Advances in clinical studies of targeted treatment for hepatocellular carcinoma
LI Qing;SUN Yan

..............page:1547-1550

Efficacy of pemetrexed therapy in patients with advanced non-small-cell lung cancer (adenocarcinoma) failed to previous chemotherapy and TKI
ZHU Guang-qing;JIN Ying;ZHANG Miao;ZHANG Yu-zhen

..............page:1596-1599

huan ying ding yue 2011 nian zhong guo yao wu hua xue za zhi

..............page:1612

Current status and advances in targeted therapy for renal cell carcinoma
SHOU Jian-zhong;MA Jian-hui

..............page:1539-1546

Management system of phase Ⅳ clinical trials
LIU Lu;WEN Bao-shu;HUANG Qing-zhu;FENG Yi;ZHANG Pei-pei;LI Guo-qing

..............page:1503-1507

Synthesis,characterization,crystal structure and physicochemical properties of picoplatin
PU Shao-ping1;2;CONG Yan-wei2;WANG Qing-kun2;BEI Yu-xiang2;LUAN Chun-fang2;LI Xue-jie2;SUN Jia-lin1

..............page:1605-1608

Compound matrine injection combined with FOLFIRI chemotherapy in the treatment of 50 patients with advanced colorectal cancer
SHI Qi;WANG Zhao-xia;ZHAO Qing-hong

..............page:1589-1592

Gastrointestinal stromal tumor and its adjuvant therapy
ZHANG Yong;LU Wei;LU Wei-qi

..............page:1563-1565,1574

Application of gelatin sponge particles to the interventional treatment of hepatic carcinoma
ZHAO Guang-sheng;YANG Xiao-hong;LI Chuang;ZHANG Yue-wei;WANG Wen-qing;TANG Shun-xiong;WANG Ruo-yu

..............page:1571-1574

Efficacy of irinotecan in combination with oxaliplatin in the treatment of metastatic colorectal cancer
LU Xi-yan;LIU Jin-ping;ZHOU Chang-fang

..............page:1578-1579,1588

zhong guo yao xue za zhi 2011 nian zheng ding qi shi

..............page:1499

Compound matrine injection combined with FOLFIRI chemotherapy in the treatment of 50 patients with advanced colorectal cancer
SHI Qi;WANG Zhao-xia;ZHAO Qing-hong

..............page:1589-1592

Individualization:a new target of medical oncology in integration of modern medicine and traditional Chinese medicine
SUN Yan

..............page:1484-1488

shi jie xin yao zhi chuang

..............page:1494-1495

Treatment of malignant ascites with intraperitoneal injection of compound Kushen injection combined cisplatin in 90 patients
HUANG Chao

..............page:1593-1595

Treatment of malignant ascites with intraperitoneal injection of compound Kushen injection combined cisplatin in 90 patients
HUANG Chao

..............page:1593-1595